Blocking enzyme could hold the key to treating severe COVID-

Blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms.

Related Keywords

Ohio , United States , Columbus , Egypt , Ohio State University , American , Jeffrey Kawahara , Jacob Yount , Eugene Oltz , Parker Denz , Ashley Zani , Xiaoli Zhang , Amy Webb , Emily Hemann , Cierra Carafice , Asmaa Badr , Mostafa Eltobgy , Eunsoo Kim , Estelle Cormet Boyaka , Adrian Eddy , Jianrong Li , Adam Kenney , Mijia Lu , Andrea Tedeschi , Maciej Pietrzak , Oscar Rosas Gavrilin , Jian Zhu , Shahid Nimjee , Richard Robinson , Emily Caldwell , Mark Peeples , Kamal Amer , Owen Whitham , Emory University , Ohio State Distinguished University Fellowship , National Institutes Of Health , Cystic Fibrosis Foundation , Columbia University , Nile University , Ohio State Department Of Microbial Infection , Proceedings Of The National Academy Sciences , American Lung Association , Ohio State University College Of Medicine , Ohio State University College , National Academy , Ohio State , National Institutes , Microbial Infection , Ohio State Distinguished University , Shady Estfanous , Kylene Daily , Prosper Boyaka , Abigail Wexner Research Institute , Nationwide Children ,